id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1993-D-0022-0003,FDA,FDA-1993-D-0022,Guideline,Supporting & Related Material,GDL-Guidance,2004-02-19T05:00:00Z,2004,2,,,2008-05-16T23:23:01Z,,0,0,09000064804fad63
FDA-1993-D-0022-0004,FDA,FDA-1993-D-0022,Guideline,Supporting & Related Material,GDL-Guidance,2004-02-19T05:00:00Z,2004,2,,,2008-05-16T23:23:01Z,,0,0,09000064804fad67
FDA-1993-D-0022-0002,FDA,FDA-1993-D-0022,FDA,Notice,N-Notice,2003-03-04T05:00:00Z,2003,3,,,2008-05-16T23:23:01Z,,0,0,09000064804fad5f
FDA-1993-D-0022-0001,FDA,FDA-1993-D-0022,FDA,Notice,NAD-Notice of Availability of Data,2001-12-31T05:00:00Z,2001,12,2001-12-27T05:00:00Z,,2008-05-16T23:23:01Z,,0,0,09000064804face9